Skip to main content
Journal cover image

MO094: Intensive Blood Pressure Lowering and Myocardial Fibrosis Biomarkers in Individuals With and Without CKD: Results From the Systolic Blood Pressure Intervention Trial (Sprint)

Publication ,  Conference
Aparna, F; Pajewski, N; Kitzman, D; Upadhya, B; Killeen, A; Rajagopalan, S; Wright, J; Rahman, M; Dobre, M
Published in: Nephrology Dialysis Transplantation
May 3, 2022

Duke Scholars

Published In

Nephrology Dialysis Transplantation

DOI

EISSN

1460-2385

ISSN

0931-0509

Publication Date

May 3, 2022

Volume

37

Issue

Supplement_3

Publisher

Oxford University Press (OUP)

Related Subject Headings

  • Urology & Nephrology
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Aparna, F., Pajewski, N., Kitzman, D., Upadhya, B., Killeen, A., Rajagopalan, S., … Dobre, M. (2022). MO094: Intensive Blood Pressure Lowering and Myocardial Fibrosis Biomarkers in Individuals With and Without CKD: Results From the Systolic Blood Pressure Intervention Trial (Sprint). In Nephrology Dialysis Transplantation (Vol. 37). Oxford University Press (OUP). https://doi.org/10.1093/ndt/gfac133.015
Aparna, Fnu, Nicholas Pajewski, Dalane Kitzman, Bharathi Upadhya, Anthony Killeen, Sanjay Rajagopalan, Jackson Wright, Mahboob Rahman, and Mirela Dobre. “MO094: Intensive Blood Pressure Lowering and Myocardial Fibrosis Biomarkers in Individuals With and Without CKD: Results From the Systolic Blood Pressure Intervention Trial (Sprint).” In Nephrology Dialysis Transplantation, Vol. 37. Oxford University Press (OUP), 2022. https://doi.org/10.1093/ndt/gfac133.015.
Aparna F, Pajewski N, Kitzman D, Upadhya B, Killeen A, Rajagopalan S, et al. MO094: Intensive Blood Pressure Lowering and Myocardial Fibrosis Biomarkers in Individuals With and Without CKD: Results From the Systolic Blood Pressure Intervention Trial (Sprint). In: Nephrology Dialysis Transplantation. Oxford University Press (OUP); 2022.
Aparna, Fnu, et al. “MO094: Intensive Blood Pressure Lowering and Myocardial Fibrosis Biomarkers in Individuals With and Without CKD: Results From the Systolic Blood Pressure Intervention Trial (Sprint).” Nephrology Dialysis Transplantation, vol. 37, no. Supplement_3, Oxford University Press (OUP), 2022. Crossref, doi:10.1093/ndt/gfac133.015.
Aparna F, Pajewski N, Kitzman D, Upadhya B, Killeen A, Rajagopalan S, Wright J, Rahman M, Dobre M. MO094: Intensive Blood Pressure Lowering and Myocardial Fibrosis Biomarkers in Individuals With and Without CKD: Results From the Systolic Blood Pressure Intervention Trial (Sprint). Nephrology Dialysis Transplantation. Oxford University Press (OUP); 2022.
Journal cover image

Published In

Nephrology Dialysis Transplantation

DOI

EISSN

1460-2385

ISSN

0931-0509

Publication Date

May 3, 2022

Volume

37

Issue

Supplement_3

Publisher

Oxford University Press (OUP)

Related Subject Headings

  • Urology & Nephrology
  • 1103 Clinical Sciences